Phase I Study of Ciliary Neurotrophic Factor (CNF) Delivered By Intravitreal Implant of Encapsulated Cell Technology (ECT) Device in Patients with Retinitis Pigmentosa
Evaluation of intravenous immunoglobulin (IVIG) as an agent to lower allosensitization and improve transplantation in highly-sensitized adult ESRD patients: report of the NIH IG02 trial